Bukwang Pharmaceutical Co., Ltd. (KRX:003000)
South Korea · Delayed Price · Currency is KRW 3,910.00
+10.00 (0.26%)
At close: Dec 18, 2025
Bukwang Pharmaceutical Market Cap
Bukwang Pharmaceutical has a market cap or net worth of 384.79 billion as of December 18, 2025. Its market cap has increased by 24.91% in one year.
Market Cap
384.79B
Enterprise Value
247.89B
Revenue
184.38B
Ranking
n/a
PE Ratio
29.87
Stock Price
3,910.00
Market Cap Chart
Since August 29, 1995, Bukwang Pharmaceutical's market cap has increased from 63.76B to 384.79B, an increase of 503.54%. That is a compound annual growth rate of 6.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 384.79B | 22.46% |
| Dec 30, 2024 | 314.21B | -24.75% |
| Dec 28, 2023 | 417.57B | -30.29% |
| Dec 29, 2022 | 598.98B | -32.17% |
| Dec 30, 2021 | 883.07B | -54.11% |
| Dec 30, 2020 | 1.92T | 109.52% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 82.86T |
| Celltrion | 40.61T |
| ALTEOGEN | 22.65T |
| ABL Bio | 10.50T |
| SK Biopharmaceuticals | 10.35T |
| Yuhan | 8.59T |
| LigaChem Biosciences | 6.27T |
| Peptron | 6.18T |